Legal Representation
Attorney
Donna M. Weinstein, Esq.
USPTO Deadlines
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 25, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Apr 25, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Aug 22, 2005 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Aug 16, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 16, 2005 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Mar 28, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Feb 18, 2005 | I | PAPER RECEIVED | Loading... | |
Feb 16, 2005 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Sep 3, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Aug 16, 2004 | I | PAPER RECEIVED | Loading... | |
Aug 16, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 17, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 25, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 5, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Sep 27, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 17, 2003 | CFIT | O | CASE FILE IN TICRS | Loading... |
Aug 21, 2003 | I | PAPER RECEIVED | Loading... | |
Aug 21, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 22, 2003 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Feb 6, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 042
BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCH FOR OTHERS, NAMELY, DEVELOPING ASSAYS FOR THE DIAGNOSIS OF DISEASE AND DISEASE PROGRESSION AND FOR THE IDENTIFICATION AND MONITORING OF THE EFFECTS OF DRUG ADMINISTRATION VIA THE MONITORING OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS; DEVELOPING METHODOLOGIES FOR BIOCHEMICAL RESEARCH TO BE USED FOR THE MONITORING OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS, NAMELY DEVELOPING MARKERS USED TO DETERMINE THE PRESENCE OF DISEASE STATES, DISEASE PROGRESSION, AND EFFECTIVENESS OF DISEASE TREATMENT; DETERMINING BIOLOGICAL PHOSPHORYLATION-RELATED TARGETS FOR DRUGS; DETERMINING PHOSPHORYLATION-RELATED BIOLOGICAL PROCESSES OR PHOSPHORYLATION-RELATED BIOLOGICAL TARGETS WHICH ARE SUSCEPTIBLE TO BEING AFFECTED BY DRUGS; DEVELOPING METHODOLOGIES IN THE FIELD OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS AND OR INSTRUMENTS RELATING THERETO IN THE FOREGOING SERVICES
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042